Notice for International Patients & Caregivers

English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.

Provincial Landscape

Snapshot: 2026-10-21

Henan Multiple Myeloma Active Trials & Centers

As of 2026-10-21, there are 38 active clinical trials for multiple myeloma hosted across 13 tertiary medical centers in Henan (including Henan Cancer Hospital, The First Affiliated Hospital of Henan University of Science and Technology, Henan Provincial People's Hospital, etc.).

Active Trials

Hospitals

Therapies

CAR-T Cell Therapy / Bispecific & Multispecific Antibodies / Monoclonal Antibodies / Oral Small-Molecule Agents

Participating Medical Centers (13)

Henan Cancer HospitalThe First Affiliated Hospital of Henan University of Science and TechnologyHenan Provincial People's HospitalPingdingshan First People's HospitalThe First Affiliated Hospital of Henan Pharmaceutical UniversityPuyang Oilfield General HospitalShangqiu First People's HospitalPuyang Anyang District HospitalJiaozuo People's HospitalThe First Affiliated Hospital of Zhengzhou UniversityNanyang Central HospitalXinxiang Central HospitalXuchang Central Hospital

Active Studies in Henan (38)

Population synthesized by CMDN

Showing 0 published English records of 38 registry trials.

All 38 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.

Back to National Landscape Filter Local Trials in the Trial Hub